AGM/EGMApr 28, 2026, 04:09 PM
FDMT Sets Annual Meeting for June 17, 2026; Key Votes
AI Summary
4D Molecular Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026. Stockholders will vote on the election of three Class III directors, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026, and an advisory vote on executive compensation. The Board of Directors recommends voting in favor of all proposals.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on June 17, 2026, at 10:30 a.m. Pacific time.
- Stockholders of record as of April 20, 2026, are eligible to vote.
- Proposals include the election of three Class III directors to serve until the 2029 annual meeting.
- Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026.
- Advisory, non-binding vote on the compensation of named executive officers (say-on-pay vote).
- Board recommends voting FOR all director nominees, FOR auditor ratification, and FOR executive compensation.
Price Impact
More from FDMT